Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
METHODS-Extend open-label methotrexate study in hand osteoarthritis
ACTRN12624000063516Phase 4Not yet recruiting
- Sponsor
- Monash University
- Start
- Jan 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of methotrexate in hand osteoarthritis, sponsored by Monash University. Primary endpoint: Change in pain at 12 months. Planned start Jan 2024; status: not yet recruiting.
02
Drugs
methotrexate
03
Conditions
hand osteoarthritis
Beyond the preview
Go deeper on ACTRN12624000063516.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12624000063516.